1 |
FDA Approval based on NDA No. 020083, $Sporanox,^{TM}$ Janssen Pharma, September 11 (1992)
|
2 |
E. M. Bailey, D. J. Krakovsky, and M. J. Rybak, The Triazole Antifungal Agents: A Review of Itraconazole and Fluconazole. Pharmacotherapy, 10, 146 (1990)
|
3 |
M. Haria, H. M. Bryson, and K. L. Goa, Itraconazole. A Reappraisal of its Pharmacological Properties and Therapeutic Use in the Management of Superficial Fungal Infections. Drugs, 51, 586 (1996)
|
4 |
J. Heeres and L. J. J. Backx (Janssen Pharmaceutica N. V.), Heterocyclic derivatives of (4-phenylpiperazin-1-yl-aryloymethyl-1, 3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles, U. S. Patent 4,267,179 (1979)
|
5 |
(c) J. Heeres, L. J. J. Backx, and J. Van Cutsem, Antimycotic Azoles. 7. Synthesis and Antifungal Properties of a Series of Novel Triazol-3-ones. J. Med. Chem., 27, 894 (1984)
DOI
|
6 |
(b) J. Heeres, R. Hendrickx, and J. Van Cutsem, Antimycotic Azoles. 6. Synthesis and Antifungal Properties of Terconazole, a Novel Triazole Ketal. J. Med. Chem., 26, 611 (1983)
DOI
|
7 |
(a) J. Heeres, L. J. J. Backx, J. H. Mostmans, and J. Van Cutsem, Antimycotic Imidazoles. Part 4. Synthesis and Antifungal Activity of Ketoconazole, a New Potent Orally Active Broad-Spectrum Antifungal Agent. J. Med. Chem., 22, 1003 (1979)
DOI
|
8 |
Y. Koltin and C. A. Hitchcock. Progress in the Search for New Triazole Antifungal Agents. Curr. Opin. Chem. Biol., 1, 176 (1997)
DOI
ScienceOn
|
9 |
건강보험심사평가원, EDI 청구액 추이 (2005)
|
10 |
C. Willis and M. Wills, Organic Synthesis, Oxford Chemistry Primers, Vol. 31, pp. 34-35, Oxford University Press Inc., New York, U.S.A. (1995)
|
11 |
D. J. Sheehan, C. A. Hitchcock, and C. M. Sibley, Current and Emerging Azole Antifungal Agents. Clinical Microbiol. Rev., 12, 40 (1999)
|